Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Antimicrob Agents Chemother ; 44(11): 3087-91, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11036027

RESUMO

A rabbit model of coccidioidal meningitis was used to compare the therapeutic efficacies of terbinafine (TBF) and fluconazole (FCZ). Hydrocortisone acetate-treated New Zealand White male rabbits were infected intracisternally with either 2.2 x 10(4) or 6.4 x 10(4) Coccidioides immitis arthroconidia. Oral treatment with polyethylene glycol 200 (PEG) twice daily (n = 8), TBF twice daily (n = 9; 200 mg/kg of body weight/day), or FCZ once daily (n = 8; 80 mg/kg/day) began on day 5 and continued for 21 days. Mean survival times were 20, 24, and 32 days for rabbits treated with PEG, TBF, and FCZ, respectively. All of the FCZ-treated animals (100%; P = 0.003), 56% of the TBF-treated animals (P = 0.4), and 25% of the PEG-treated animals survived the length of the study. Both FCZ and TBF were effective at reducing the incidence of paresis. Only FCZ was effective at reducing most neurological and systemic signs. FCZ treatments resulted in lower cerebrospinal fluid (CSF) protein concentrations and leukocyte counts and faster clearing of CSF fungal cultures compared with those for PEG-treated controls, but TBF treatments had no significant effect on these parameters. Neither drug affected CSF glucose levels. Mean serum TBF levels by bioassay were within the range of 3.5 to 6.2 microgram/ml at 1, 2, and 4 h postdosing and 0.35 to 7.0 microgram/ml at 14 h postdosing. No TBF was detected in CSF. Mean FCZ levels (24 to 25.5 h postdosing) by bioassay were 16.4 to 19.2 and 13.5 to 19.2 microgram/ml in serum and CSF, respectively. The reduction in the numbers of CFU in the spinal cord and brain was over 100-fold (P = 0.0005) in FCZ-treated animals and 2-fold (P

Assuntos
Antifúngicos/uso terapêutico , Coccidioidomicose/tratamento farmacológico , Fluconazol/uso terapêutico , Meningite Fúngica/tratamento farmacológico , Naftalenos/uso terapêutico , Animais , Antifúngicos/sangue , Antifúngicos/líquido cefalorraquidiano , Líquido Cefalorraquidiano/citologia , Líquido Cefalorraquidiano/microbiologia , Coccidioides/efeitos dos fármacos , Coccidioidomicose/patologia , Ensaio de Unidades Formadoras de Colônias , Modelos Animais de Doenças , Fluconazol/sangue , Fluconazol/líquido cefalorraquidiano , Glucose/líquido cefalorraquidiano , Leucócitos , Masculino , Meningite Fúngica/patologia , Testes de Sensibilidade Microbiana , Naftalenos/sangue , Naftalenos/líquido cefalorraquidiano , Coelhos , Terbinafina , Resultado do Tratamento
2.
Clin Neuropharmacol ; 14(3): 256-61, 1991 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1906375

RESUMO

The capability of pravastatin and lovastatin, HMG-CoA reductase inhibitors likely to be taken chronically for hypercholesterolemia, to cross the blood-brain barrier was investigated in normal male volunteers. Lovastatin, which is lipophilic, was detected in cerebrospinal fluid (CSF) at concentrations that may have a pharmacologic effect. Pravastatin, which is hydrophilic, was not detected in CSF. It is concluded that pravastatin may have less potential for causing CNS-related side effects than lovastatin.


Assuntos
Anticolesterolemiantes/líquido cefalorraquidiano , Ácidos Heptanoicos/líquido cefalorraquidiano , Lovastatina/líquido cefalorraquidiano , Naftalenos/líquido cefalorraquidiano , Adulto , Anticolesterolemiantes/farmacocinética , Barreira Hematoencefálica , Ácidos Heptanoicos/farmacocinética , Humanos , Lovastatina/farmacocinética , Masculino , Naftalenos/farmacocinética , Pravastatina , Valores de Referência
5.
Biochem J ; 103(1): 79-85, 1967 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-6033776

RESUMO

1. Five new solvent systems are reported for the separation of 1-dimethylaminonaphthalene-5-sulphonylamino acids by thin-layer chromatography on silica gel. After two-dimensional chromatography with a suitable pair of these solvent systems, most of the 1-dimethylaminonaphthalene-5-sulphonyl derivatives were completely separated and could be located by their intense yellow fluorescence when viewed under u.v. light. 2. These techniques have been used to identify 21 amino acids present in superfusates of cat cerebral cortex, plasma and cerebrospinal fluid. 3. A method for the semiquantitative estimation of amino acids in biological fluids is described in which the fluorescent intensity of their separated 1-dimethylaminonaphthalene-5-sulphonyl derivatives was measured.


Assuntos
Aminoácidos/análise , Córtex Cerebral/análise , Naftalenos/análise , Aminoácidos/sangue , Aminoácidos/líquido cefalorraquidiano , Animais , Gatos , Cromatografia em Camada Fina , Naftalenos/sangue , Naftalenos/líquido cefalorraquidiano , Solventes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA